Literature DB >> 17130774

Marginal lung donors: A diminishing margin of safety?

Phil Botha1, Andrew J Fisher, John H Dark.   

Abstract

Lung donor shortages have resulted in the critical appraisal of cadaveric donor acceptability criteria and the gradual relaxation of once strict guidelines. Many centers have reported their results with these "extended criteria" donors and an increasing number of multicenter registry studies have also been published. The results have been contradictory and leave many questions unanswered. Important new data has however come to light since the last review of the subject by the International Society for Heart and Lung Transplantation Pulmonary Council. We review the current literature focusing on recent developments in the pursuit of an expanded lung donor pool with acceptable outcomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17130774     DOI: 10.1097/01.tp.0000236099.52382.74

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Single-lung transplantation in a chronic pulmonary emphysema patient with a marginal donor who was ABO blood group nonidentical but compatible.

Authors:  Yoshiyuki Susaki; Masayoshi Inoue; Masato Minami; Yasushi Shintani; Tomoyuki Nakagiri; Noriyoshi Sawabata; Meinoshin Okumura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-03-28

2.  Successful lung transplantation from a donor with persistent lobar atelectasis.

Authors:  Aditya Bansal; Norihisa Shigemura; Yoshiya Toyoda; Jay K Bhama
Journal:  Ochsner J       Date:  2014

3.  Benefit of a single recruitment maneuver after an apnea test for the diagnosis of brain death.

Authors:  Marie Paries; Nicolas Boccheciampe; Mathieu Raux; Bruno Riou; Olivier Langeron; Armelle Nicolas-Robin
Journal:  Crit Care       Date:  2012-07-03       Impact factor: 9.097

4.  Current Status and Future of Lung Donation in Korea.

Authors:  Hye Ju Yeo; Seong Hoon Yoon; Seung Eun Lee; Doosoo Jeon; Yun Seong Kim; Woo Hyun Cho; Do Hyung Kim
Journal:  J Korean Med Sci       Date:  2017-12       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.